Literature DB >> 34644165

Alterations in the Transcriptional Landscape Allow Differential Desiccation Tolerance in Clinical Cronobacter sakazakii.

Yu Cao1, Katherine Dever1, Sathesh Kumar Sivasankaran2, Scott V Nguyen1,3, Guerrino Macori1, Ankita Naithani1, Gopal R Gopinath4, Ben Tall5, Angelika Lehner6, Roger Stephan6, Shabarinath Srikumar2, Séamus Fanning1.   

Abstract

Cronobacter sakazakii is a typical example of a xerotolerant bacterium. It is epidemiologically linked to low-moisture foods like powdered infant formula (PIF) and is associated with high fatality rates among neonates. We characterized the xerotolerance in a clinically isolated strain, Cronobacter sakazakii ATCC™29544T, and compared the desiccation tolerance with that of an environmental strain, C. sakazakii SP291, whose desiccation tolerance was previously characterized. We found that, although the clinical strain was desiccation-tolerant, the level of tolerance was compromised when compared with that of the environmental strain. Transcriptome sequencing (RNA-seq)-based deep transcriptomic characterization identified a unique transcriptional profile in the clinical strain compared with what was already known for the environmental strain. As RNA-seq was also carried out under different TSB growth conditions, genes that were expressed specifically under desiccated conditions were identified and denoted as desiccation responsive genes (DRGs). Interestingly, these DRGs included transcriptomic factors like fnr, ramA, and genes associated with inositol metabolism, a phenotype as yet unreported in C. sakazakii. Further, the clinical strain did not express the proP gene, which was previously reported to be very important for desiccation survival and persistence. Interestingly, analysis of the plasmid genes showed that the iron metabolism in desiccated C. sakazakii ATCC™29544T cells specifically involved the siderophore cronobactin, encoded by the iucABCD genes. Confirmatory studies using quantitative reverse transcription-PCR (qRT-PCR) determined that, though the secondary desiccation response genes were upregulated in C. sakazakii ATCC™29544T, the level of upregulation was lower than that in C. sakazakii SP291. All these factors may collectively contribute to the compromised desiccation tolerance in the clinical strain. IMPORTANCE Cronobacter sakazakii has led to outbreaks in the past, particularly associated with foods that are low in moisture content. This species has adapted to survive in low water conditions and can survive in such environments for long periods. These characteristics have enabled the pathogen to contaminate powder infant formula, a food matrix with which the pathogen has been epidemiologically associated. Even though clinically adapted strains can also be isolated, there is no information on how the clinical strains adapt to low moisture environments. Our research assessed the adaptation of a clinically isolated strain to low moisture survival on sterile stainless steel coupons and compared the survival with that of a highly desiccation-tolerant environmental strain. We found that, even though the clinical strain is desiccation-tolerant, the rate of tolerance was compromised compared with that of the environmental strain. A deeper investigation using RNA-seq identified that the clinical strain used pathways different from that of the environmental strain to adapt to low-moisture conditions. This shows that the adaptation to desiccation conditions, at least for C. sakazakii, is strain-specific and that different strains have used different evolutionary strategies for adaptation.

Entities:  

Keywords:  Cronobacter sakazakii; RNA sequencing; desiccation; production environment

Mesh:

Year:  2021        PMID: 34644165      PMCID: PMC8612285          DOI: 10.1128/AEM.00830-21

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   5.005


  44 in total

Review 1.  Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence.

Authors:  Roy D Sleator; Colin Hill
Journal:  FEMS Microbiol Rev       Date:  2002-03       Impact factor: 16.408

Review 2.  Enterobacter sakazakii: a review.

Authors:  M Nazarowec-White; J M Farber
Journal:  Int J Food Microbiol       Date:  1997-02       Impact factor: 5.277

3.  An in silico analysis of osmotolerance in the emerging gastrointestinal pathogen Cronobacter sakazakii.

Authors:  Audrey Feeney; Roy D Sleator
Journal:  Bioeng Bugs       Date:  2011-09-01

4.  Regulation of compatible solute accumulation in Salmonella typhimurium: evidence for a glycine betaine efflux system.

Authors:  S P Koo; C F Higgins; I R Booth
Journal:  J Gen Microbiol       Date:  1991-11

5.  progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement.

Authors:  Aaron E Darling; Bob Mau; Nicole T Perna
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

6.  Acid stress management by Cronobacter sakazakii.

Authors:  Avelino Alvarez-Ordóñez; Conor Cummins; Thérèse Deasy; Tanya Clifford; Máire Begley; Colin Hill
Journal:  Int J Food Microbiol       Date:  2014-03-11       Impact factor: 5.277

7.  How deep is deep enough for RNA-Seq profiling of bacterial transcriptomes?

Authors:  Brian J Haas; Melissa Chin; Chad Nusbaum; Bruce W Birren; Jonathan Livny
Journal:  BMC Genomics       Date:  2012-12-27       Impact factor: 3.969

8.  Insertion-sequence-mediated mutations both promote and constrain evolvability during a long-term experiment with bacteria.

Authors:  Jessika Consuegra; Joël Gaffé; Richard E Lenski; Thomas Hindré; Jeffrey E Barrick; Olivier Tenaillon; Dominique Schneider
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

9.  Complete genome sequence and phenotype microarray analysis of Cronobacter sakazakii SP291: a persistent isolate cultured from a powdered infant formula production facility.

Authors:  Qiongqiong Yan; Karen A Power; Shane Cooney; Edward Fox; Gopal R Gopinath; Christopher J Grim; Ben D Tall; Matthew P McCusker; Séamus Fanning
Journal:  Front Microbiol       Date:  2013-09-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.